Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23146)

Formulation Name

Edaravone 30 mg/100 ml Injection

Company

Mitsubishi Tanabe Pharma America

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
MCI-186	DM8ZHP1	Amyotrophic lateral sclerosis	8B60.0	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Cysteine hydrochloride	E00318	25150	Antioxidant
Phosphoric acid	E00039	1004	Acidulant; Buffering agent
Sodium chloride	E00077	5234	Diluent; Tonicity agent
Sodium hydroxide	E00234	14798	Alkalizing agent
Sodium sulhydrate	E00549	23665763	Antimicrobial preservative

--------------------